Influenza Clinical Trials
Influenza clinical trials test new treatments, vaccines, and prevention strategies for influenza. Corterve compiles actively recruiting Influenza studies from the ClinicalTrials.gov registry so you can filter by where you live and whether you may qualify. This page is educational and not medical advice; consult a qualified clinician about participating.
Recruiting Influenza studies
- BPL-1357 Against H1N1 Influenza Virus ChallengeNCT07215858PHASE2National Institute of Allergy and Infectious Diseases (NIAID)InfluenzaBethesda, Maryland
- Light-based Immunomodulation for Guarding Against Human Respiratory Tract InfectionsNCT07610967NADavid MossCOVID-19 Respiratory InfectionNellis Air Force Base, Nevada
- pH1N1 Blinded Challenge StudyNCT07110532PHASE1National Institute of Allergy and Infectious Diseases (NIAID)InfluenzaBaltimore, Maryland
- Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)NCT06160128VA Office of Research and DevelopmentCOVID-19, SARS-CoV-2 InfectionPortland, Oregon
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) RecipientsNCT05947071PHASE2National Institute of Allergy and Infectious Diseases (NIAID)Immunization; InfectionStanford, California
- A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsNCT06094010PHASE3Hoffmann-La RocheInfluenzaBirmingham, Alabama
- Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNCT01386424National Institute of Allergy and Infectious Diseases (NIAID)ZikaBethesda, Maryland
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of AgeNCT07805707PHASE3GlaxoSmithKlineInfluenza, HumanAnniston, Alabama
- Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy AdultsNCT06863142PHASE1National Institute of Allergy and Infectious Diseases (NIAID)Influenza PreventionBethesda, Maryland
- Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.NCT07779408PHASE1, PHASE2SanofiHealthy VolunteersTempe, Arizona
- Observational Digital Biomarker Discovery in Respiratory Virus Challenge StudiesNCT04772170National Institute of Allergy and Infectious Diseases (NIAID)InfluenzaBethesda, Maryland
- Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy AdultsNCT07111078PHASE1National Institute of Allergy and Infectious Diseases (NIAID)Influenza PreventionBethesda, Maryland
Influenza trials by state
Influenza trials by metro
Frequently asked questions
- How do I find recruiting Influenza clinical trials?
- Browse the actively recruiting Influenza studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Influenza clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Influenza clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.